Financial reports
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
28 Jul 23
10-K
2022 FY
Annual report
28 Jul 23
NT 10-Q
Notice of late quarterly filing
15 May 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
2 Sep 22
Current reports
8-K
Entry into a Material Definitive Agreement
11 Jan 24
8-K
Avenir Wellness Solutions Announces Return of Stock Trading Back to Otcqb Market
19 Sep 23
8-K
Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
11 Aug 23
8-K
Avenir Wellness Solutions Update to Stockholders
19 May 23
8-K
Changes in Registrant's Certifying Accountant
20 Apr 23
8-K
Changes in Registrant's Certifying Accountant
19 Apr 23
8-K
Entry into a Material Definitive Agreement
8 Mar 23
8-K
New branding reflects Company’s commitment to the future of wellness
17 Jan 23
8-K
Departure of Directors or Certain Officers
19 Aug 22
8-K
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
28 Jul 22
Registration and prospectus
S-3
Shelf registration
30 Nov 20
S-8
Registration of securities for employees
25 Nov 20
D
$11.5M in debt / options / securities to be acquired, sold $11.5M, 1 investor
13 Nov 20
D/A
$19.04M in equity, sold $19.04M, 25 investors
29 May 19
D
$19.04M in equity, sold $19.04M, 25 investors
29 May 19
RW
Registration withdrawal request
12 Apr 19
S-1/A
IPO registration (amended)
30 Nov 18
S-8
Registration of securities for employees
11 Oct 18
RW
Registration withdrawal request
5 Oct 18
S-1
IPO registration
9 Jul 18
Other
EFFECT
Notice of effectiveness
10 Dec 20
CORRESP
Correspondence with SEC
7 Dec 20
UPLOAD
Letter from SEC
4 Dec 20
UPLOAD
Letter from SEC
3 Jul 19
CORRESP
Correspondence with SEC
2 Jul 19
UPLOAD
Letter from SEC
27 Jun 19
CORRESP
Correspondence with SEC
26 Jun 19
UPLOAD
Letter from SEC
24 Jun 19
UPLOAD
Letter from SEC
1 Nov 17
CORRESP
Correspondence with SEC
30 Oct 17